Phialogics

phialogics.com
startup-icon Start-up

Phialogics AG

Hegenheimermattweg 167A
c/o Swiss Innovation Park Basel Area
4123 Allschwil
Switzerland
phialogics.com
Profile News

About Phialogics

We are a preclinical company developing cell-type-specific immune checkpoint activators to prevent multi-organ failure in autoimmune diseases.

We engineer next generation biologics that rebalance the immune response in acute and chronic inflammation.

Read more about Phialogics

Advertisement

Commercial-Scale Single-Use Tangential Flow Filtration for Automated Bioprocessing
Commercial-Scale Single-Use Tangential Flow Filtration for Automated Bioprocessing
Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing
Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing
High‑Performance Tangential Flow Filtration Solutions for Biopharmaceutical Processing
High‑Performance Tangential Flow Filtration Solutions for Biopharmaceutical Processing

News about Phialogics

Phialogics

18-Jul-2023 | business & finance

Pioneering research projects at the 8th Life Science Pitch Day at the IZB

A total of sixteen teams presented their innovative ideas to almost 50 investors at the Munich start-up center.

Read news
Show more news about Phialogics

Advertisement

Digital membrane chromatography opens up new horizons in protein analysis
Digital membrane chromatography opens up new horizons in protein analysis
Advanced Virus Quantification for Real-Time Process Control
Advanced Virus Quantification for Real-Time Process Control
Maximum binding capacity in ion exchange chromatography
Maximum binding capacity in ion exchange chromatography

Here you will find Phialogics AG

Last viewed contents

ErVimmune - Lyon, France

ErVimmune - Lyon, France

Go to page
Imegen - Paterna, Spain

Imegen - Paterna, Spain

Go to page
Invitria - Fort Collins, USA

Invitria - Fort Collins, USA

Go to page